Welcome to episode 80 of AI in Action, the podcast that breaks down the hype and explores the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today's guest is Alix Lacoste, VP of Data Science at BenevolentAI in New York. BenevolentAI is the global leader in the development and application of AI for scientific innovation. They aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.
BenevolentAI's team of technologists, AI researchers and scientists build and applies AI to the entire drug discovery and development process. Alix leads the Data Science team, who responsible for developing machine learning and data science technologies to improve and evaluate the drug target identification pipeline from rare to more common diseases.
In the show, Alix will tell you about:
How she got involved in the Data Science world
What is unique about Benevolent’s work within healthcare
Their goal to fulfil the potential of AI within drug discovery
Interesting projects she is currently working on
What she loves about her job
Challenges to be aware of in building a successful data science team
What did you make of Alix's podcast? How do you think Artificial Intelligence and Data Science will continue to impact the healthcare industry? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.